We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Software Tool Simulates Results of Pediatric Heart Surgery

By HospiMedica International staff writers
Posted on 10 Dec 2009
A software tool that simulates blood flow on a computer can help optimize surgical design in babies born with severe congenital heart defects.

Researchers at the University of California, San Diego (UCSD, USA) and Stanford University (CA, USA) developed the new computational tool to assist surgeons in planning Fontan surgery, one of three procedures performed immediately after birth to redirect the circulation of children born with a missing or underdeveloped left ventricle. More...
The tool first uses imaging data to construct a model of an individual baby's heart. Surgeons can then use a computer to systematically explore different potential surgical designs, using powerful optimization algorithms. Fluid dynamics can then be used to simulate the blood flow after reconstruction, allowing the surgeons to test their surgical designs and evaluate future blood-flow patterns before actually operating. The new software tool was presented at the 62nd Annual Meeting of the American Physical Society's (APS) Division of Fluid Dynamics, held during November 2009 in Minneapolis (MN, USA).

"Our ultimate goal is to optimize surgeries that are tailored for individual patients so that we don't have to rely on a ‘one-size fits all' solution,” said study presenter Alison Marsden, M.D., of UCSD.

The Fontan procedure is a palliative surgical procedure used in children with complex congenital heart defects. It involves diverting the venous blood from the right atrium to the pulmonary arteries without passing through the morphologic right ventricle, essentially connecting the veins that would normally bring blood into the right side of the heart with the pulmonary arteries, allowing the patient to survive with only one functional pumping chamber. It was initially described in 1971 as a surgical treatment for tricuspid atresia.

Related Links:
University of California, San Diego
Stanford University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.